TY  - GEN 
AU  - Pereyra-Rodriguez, José-Juan
AU  - Poveda, J.L.
AU  - Rivero, A.
AU  - Serra Baldrich, E.
AU  - Silvestre, J.F.
AU  - Armario Hita, José Carlos
AU  - Calleja, M.A.
AU  - Carrascosa, J. M.
AU  - Flórez, A.
AU  - Herranz, P.
AU  - Comellas, M.
AU  - Ortiz de Frutos, F.J.
A4  - Medicina
PY  - 2024
SN  - 1468-3083
SN  - 0926-9959
UR  - http://hdl.handle.net/10498/31506
AB  - Dear Editor,
The increased understanding of atopic dermatitis (AD)
pathophysiology has shed light on the underlying immuno-
logical mechanisms and spurred the development of novel,
more precisely targeted therapies.1 As new agents...
LA  - eng
PB  - John Wiley and Sons Inc
KW  - Decision Making
KW  - Decision Support Techniques
KW  - Dermatitis, Atopic
KW  - Humans
KW  - atopic dermatitis
KW  - clinical decision making
KW  - clinical outcome
KW  - conceptual framework
KW  - dermatologist
KW  - disease activity
KW  - disease control
KW  - disease severity
KW  - drug cost;
KW  - drug safety
KW  - hospital pharmacist
KW  - human
KW  - incidence
KW  - Letter
KW  - multicriteria decision analysis
KW  - pain
KW  - patient-reported outcome
KW  - pruritus
KW  - publication
KW  - quality of life
KW  - sleep disorder
KW  - atopic dermatitis
KW  - decision making
KW  - decision support system
TI  - Assessing the value of moderate-to-severe atopic dermatitis treatment using multi-criteria decision analysis (MCDA)
DO  - 10.1111/JDV.19432
ER  -